Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Adipose-Derived Stem Cells Alleviate Denervation-Induced Muscle Atrophy by Promoting M2 Macrophage Polarization and Reducing Inflammation.

Zhao Q., Sowa Y., Koh O., Li Y., Sakamoto M., Higai S.

Animal Study on Knee, published in Muscle Nerve (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Muscle Nerve (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41366198
DOI
10.1002/mus.70094

Abstract (original English)

Denervation-induced muscle atrophy lacks effective therapies. Adipose-derived stem cells (ADSCs) show promise for tissue repair. This study aimed to evaluate the effect of local ADSC delivery on denervated muscle, investigate underlying mechanisms, and track ADSC distribution and migration in vivo. In a mouse model of sciatic nerve transection and immediate reverse autograft repair, ADSCs or phosphate-buffered saline (PBS) were injected into the right gastrocnemius following nerve injury. Magnetic resonance imaging (MRI) and in vivo imaging system (IVIS) tracked ADSC migration. Muscle strength and gastrocnemius mass were measured. Histology (H&E, Masson), immunostaining (MyoD, CD163), and the real-time reverse transcription polymerase chain reaction (RT-PCR) assessed fiber size, fibrosis, muscle regeneration, M2 macrophage infiltration, and inflammatory gene expression. Endpoints were measured 1 week after the final injection (4 weeks post-injury). IVIS showed that injected ADSCs were visualized for 3-5 days in vivo while MRI localized cells predominantly to the quadriceps and knee regions. ADSC treatment increased normalized muscle strength (p < 0.05), normalized gastrocnemius muscle weight (p < 0.001) and fiber diameter (p < 0.05); downregulated MMP2 expression (p < 0.001), enhanced MyoD+ cell count (p < 0.001), and promoted M2 macrophage infiltration (CD163+ cells, p < 0.05;

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMuscular AtrophyMiceMacrophagesInflammationAdipose TissueMaleMice, Inbred C57BLMuscle, SkeletalStem Cell Transplantation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research